Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2008-01-07 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BREST (29200), Finistere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE FEYS : revenue, balance sheet and financial ratios
PHARMACIE FEYS is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BREST (29200),
this company of category PME
shows in 2022 a revenue of 920 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE FEYS (SIREN 502643547)
Indicator
2024
2023
2022
2021
2020
2019
2017
Revenue
N/C
N/C
920 010 €
N/C
N/C
N/C
N/C
Net income
37 876 €
50 928 €
50 282 €
44 321 €
44 970 €
34 205 €
65 522 €
EBITDA
N/C
N/C
83 137 €
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
5.5%
N/C
N/C
N/C
N/C
Revenue and income statement
Im Jahr 2024 erzielt PHARMACIE FEYS ein positives Nettoergebnis von 38 k€. Entwicklung 2017-2024: 66 k€ -> 38 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
37 876 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt 19%. Dieses niedrige Niveau spiegelt eine solide Finanzstruktur wider. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht 78%. Diese hohe Autonomie bedeutet, dass das Unternehmen den Großteil seiner Vermögenswerte durch Eigenkapital finanziert.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
19.45%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
77.558%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2019
2020
2021
2022
2023
2024
Debt ratio
83.857
79.709
63.904
49.67
37.037
25.839
19.45
Financial autonomy
50.799
51.558
56.208
61.588
66.299
71.597
77.558
Repayment capacity
None
None
None
None
3.758
None
None
Cash flow / Revenue
None%
None%
None%
None%
7.419%
None%
None%
Sector positioning
Verschuldungsgrad
19.452024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Gut
Im Jahr 2024 liegt unter dem Median der Branche das verschuldungsgrad von PHARMACIE FEYS (19.45). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Diese kontrollierte Position spiegelt umsichtiges Management wider.
Finanzielle Autonomie
77.56%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Ausgezeichnet+6 pts over 3 years
Im Jahr 2024 liegt in den oberen 25% der Branche das finanzielle autonomie von PHARMACIE FEYS (77.6%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Hohe Autonomie spiegelt finanzielle Unabhängigkeit und Fähigkeit wider, Schocks zu absorbieren.
Rückzahlungsfähigkeit
3.76 ans2022
2022
Q1: 1.29 ans
Med: 3.55 ans
Q3: 6.63 ans
Average
Im Jahr 2022 liegt über dem Median der Branche das rückzahlungsfähigkeit von PHARMACIE FEYS (3.8 ans). Dieses Verhältnis gibt die Anzahl der Jahre an, die zur Rückzahlung der Schulden mit dem Cashflow benötigt werden. Eine Reduzierung könnte die finanzielle Stärke verbessern.
Liquidity ratios
Die Liquiditätsquote beträgt 95.39. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
95.387
Liquidity indicators evolution PHARMACIE FEYS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2019
2020
2021
2022
2023
2024
Liquidity ratio
124.336
113.985
114.961
92.822
95.439
102.844
95.387
Interest coverage
None
None
None
None
4.864
None
None
Sector positioning
Liquiditätsquote
95.392024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Beobachten
Im Jahr 2024 liegt in den unteren 25% der Branche das liquiditätsquote von PHARMACIE FEYS (95.39). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Ein Verhältnis unter 1 kann auf potenzielle Liquiditätsspannungen hinweisen.
Zinsdeckung
4.86x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Gut
Im Jahr 2022 liegt über dem Median der Branche das zinsdeckung von PHARMACIE FEYS (4.9x). Dieses Verhältnis gibt an, wie oft das Betriebsergebnis die Zinsaufwendungen deckt. Diese komfortable Position bietet eine nennenswerte Sicherheitsmarge.
Working capital requirement (WCR) and payment terms
Der Betriebskapitalbedarf (WCR) misst die zeitliche Lücke.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE FEYS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
54 639 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
21
0
0
Customer payment term (days)
0
0
0
0
6
0
0
Supplier payment term (days)
0
0
0
0
38
0
0
Positioning of PHARMACIE FEYS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE FEYS is estimated at
528 776 €
(range 368 231€ - 791 080€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
368k€528k€791k€
528 776 €Range: 368 231€ - 791 080€
NAF 5 année 2024
Valuation method used
Net Income Multiple
37 876 €
×
14.0x
=528 777 €
Range: 368 232€ - 791 081€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE FEYS with other companies in the same sector:
Yes, PHARMACIE FEYS generated a net profit of 38 k€ in 2024.
Where is the headquarters of PHARMACIE FEYS ?
The headquarters of PHARMACIE FEYS is located in BREST (29200), in the department Finistere.
Where to find the tax return of PHARMACIE FEYS ?
The tax return of PHARMACIE FEYS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE FEYS operate?
PHARMACIE FEYS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart